Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
Titel:
Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer
Auteur:
Smit, E.F. Socinski, M.A. Mullaney, B.P. Myrand, S.P. Scagliotti, G.V. Lorigan, P. Reck, M. Ciuleanu, T. von Pawel, J. Karaseva, N.A. Szczesna, A. Ohannesian, D. Powell, E. Hozak, R.R. Hong, S. Guba, S.C. Thatcher, N.